-+ 0.00%
-+ 0.00%
-+ 0.00%

Vanda Pharmaceuticals director Duncan files initial beneficial ownership statement

PUBT·04/24/2026 20:36:57
Listen to the news
Vanda Pharmaceuticals director Duncan files initial beneficial ownership statement
  • Vanda Pharmaceuticals director Duncan Charles Cliff filed an initial Form 3 on April 24, 2026, covering holdings as of April 22, 2026.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vanda Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0002130896-26-000006), on April 24, 2026, and is solely responsible for the information contained therein.